Legal & General Group
ASMB icon

Legal & General Group’s Assembly Biosciences ASMB Stock Holding History

Legal & General Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3K Buy
+958
New +$26.1K ﹤0.01% 3002
2021
Q3 		– Sell
-175
Closed -$8K – 3497
2021
Q2 		$8K Sell
175
-355
-67% -$17.6K ﹤0.01% 3436
2021
Q1 		$29K Buy
530
+27
+5% +$1.79K ﹤0.01% 2997
2020
Q4 		$37K Hold
503
– – ﹤0.01% 2887
2020
Q3 		$100K Sell
503
-105
-17% -$26.4K ﹤0.01% 2490
2020
Q2 		$170K Buy
608
+73
+14% +$17K ﹤0.01% 2392
2020
Q1 		$95K Sell
535
-34
-6% -$7.29K ﹤0.01% 2426
2019
Q4 		$140K Buy
569
+6
+1% +$1.1K ﹤0.01% 2491
2019
Q3 		$66K Buy
563
+175
+45% +$26.5K ﹤0.01% 2650
2019
Q2 		$63K Buy
388
+48
+14% +$9.12K ﹤0.01% 2678
2019
Q1 		$80K Buy
340
+19
+6% +$4.81K ﹤0.01% 2558
2018
Q4 		$87K Buy
321
+47
+17% +$13.6K ﹤0.01% 2493
2018
Q3 		$122K Buy
274
+51
+23% +$23.9K ﹤0.01% 2460
2018
Q2 		$105K Sell
223
-26
-10% -$13.7K ﹤0.01% 2485
2018
Q1 		$146K Sell
249
-70
-22% -$43.4K ﹤0.01% 2369
2017
Q4 		$171K Sell
319
-30
-9% -$13.6K ﹤0.01% 2378
2017
Q3 		$145K Sell
349
-503
-59% -$154K ﹤0.01% 2450
2017
Q2 		$212K Buy
+852
New +$240K ﹤0.01% 2280

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Legal & General Group's ASMB Position: Q2 2026 in Review

Legal & General Group opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 958 shares worth $26.3K. The stake represents ﹤0.01% of the portfolio and ranks #3002 among its holdings. This is a return to the name: Legal & General Group previously reported a position in ASMB as recently as Q2 2021.

Legal & General Group first reported a position in ASMB in Q2 2017 and has held it in 18 quarters since. The position peaked at $212K in Q2 2017. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Legal & General Group held 958 shares of Assembly Biosciences worth $26.3K as of Q2 2026.
  • Assembly Biosciences was a new Legal & General Group position in Q2 2026.
  • Assembly Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3002 holding.
  • Legal & General Group first reported a position in Assembly Biosciences in Q2 2017 and has held it in 18 quarters since.
  • Legal & General Group's Assembly Biosciences position peaked at $212K in Q2 2017.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.